Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Mar. 2025,
Ryman Healthcare paid$0.0 Mil more to buy back shares than it received from issuing new shares.
It spent$523.7 Mil paying down its debt.
It paid$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received$0.0 Mil from paying cash dividends to shareholders.
It received$555.9 Mil on other financial activities.
In all, Ryman Healthcareearned$32.2 Mil on financial activities for the
six
months ended in Mar. 2025.
Ryman Healthcare (OTCPK:RYHTY) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Ryman Healthcare's issuance of stock for the
six
months ended in Mar. 2025 was $0.0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Ryman Healthcare's repurchase of stock for the
six
months ended in Mar. 2025 was $0.0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Ryman Healthcare's net issuance of debt for the
six
months ended in Mar. 2025 was $-523.7 Mil.
Ryman Healthcare spent$523.7 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Ryman Healthcare's net issuance of preferred for the
six
months ended in Mar. 2025 was $0.0 Mil.
Ryman Healthcare paid$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Ryman Healthcare's cash flow for dividends for the
six
months ended in Mar. 2025 was $0.0 Mil.
Ryman Healthcare received$0.0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Ryman Healthcare's other financing for the
six
months ended in Mar. 2025 was $555.9 Mil.
Ryman Healthcare received$555.9 Mil on other financial activities.
Ryman Healthcare Cash Flow from Financing Related Terms
Ryman Healthcare Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Ryman Healthcare's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ryman Healthcare Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Ryman Healthcare's Cash from Financing for the fiscal year that ended in Mar. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $54.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of $54.0 Mil mean?
Ryman Healthcare (RYHTY) has a Cash Flow from Financing of $54.0 Mil as of Mar. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Ryman Healthcare and its competitors.
Is Ryman Healthcare's Cash Flow from Financing too high?
Ryman Healthcare's current Cash Flow from Financing is $54.0 Mil. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's Cash Flow from Financing compare to HCA and THC?
Ryman Healthcare's Cash Flow from Financing of $54.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Ryman Healthcare and its competitors. Ryman Healthcare's current Cash Flow from Financing is $54.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current Cash Flow from Financing of $54.0 Mil. The current Cash Flow from Financing is $54.0 Mil. Ryman Healthcare's overall GF Score™ is 70/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current Cash Flow from Financing is $54.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score
Get the complete analysis for RYHTY
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYHTY has been successfully added to your 
